Published in Pathol Biol (Paris) on November 01, 1973
Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol (1971) 6.97
Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood (1990) 3.02
Bleeding in renal failure: a possible cause. Br Med J (1976) 2.82
An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol (1974) 2.01
Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci U S A (1992) 1.95
Diabetes mellitus after abdominal radiation therapy. Lancet (1995) 1.79
Specific roles for platelet surface glycoproteins in platelet function. Nature (1975) 1.77
Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med (2001) 1.75
The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets. Semin Hematol (1979) 1.71
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.63
Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest (1981) 1.62
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med (1976) 1.58
Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function. Blood (1978) 1.47
Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol (1983) 1.47
Induction of DNA synthesis in rat macrophages in vitro by inflammatory exudate. Nature (1975) 1.45
Distribution of prostaglandins in inflammatory exudate. J Pathol (1973) 1.45
Evidence for an endogenous antigen in the adjuvant arthritic rat. J Pathol (1973) 1.40
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia (1997) 1.40
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients. Diabetes Care (1995) 1.40
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines. J Lab Clin Med (1996) 1.39
Relationships between inhibition of rat polymorphonuclear chemotaxis and various inflammatory reactions. Agents Actions (1979) 1.36
A molecular defect in thrombasthenic platelets. J Clin Invest (1975) 1.36
A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol (1999) 1.34
Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med (1981) 1.24
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
The interrelations of complement and a prostaglandin-like substance in acute inflammation. J Pathol (1970) 1.18
Calcium pyrophosphate-induced pleurisy in rats: a new model of acute inflammation. Agents Actions (1975) 1.18
Further studies on carrageenan-induced pleurisy in rats. J Pathol (1975) 1.17
Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol (1981) 1.15
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. Leukemia (2004) 1.13
Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium. Prostaglandins (1978) 1.11
Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ (2002) 1.10
Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome. Blood (1982) 1.10
Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes (1998) 1.10
Platelet aggregation in mammalians (human, rat, rabbit, guinea-pig, horse, dog). A comparative study. Thromb Diath Haemorrh (1967) 1.10
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood (1999) 1.09
Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis (1987) 1.09
The role of polymorphonuclear leucocytes in acute inflammation in agranulocytic rats. J Pathol (1969) 1.08
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood (1998) 1.08
Rectal lymphogranuloma venereum surveillance in France 2004-2005. Euro Surveill (2006) 1.08
The use of the air pouch to study experimental synovitis and cartilage breakdown. Biomed Pharmacother (1986) 1.07
Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study. Diabetologia (2008) 1.07
Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol (2001) 1.07
Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients. Diabetes Res (1990) 1.07
Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphate. J Biol Chem (1991) 1.06
Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet (1997) 1.06
Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci (1993) 1.05
Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed-immunoelectrophoresis. Blood (1981) 1.05
Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab (2000) 1.04
Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease. J Clin Pathol (1975) 1.04
Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours. Clin Pharmacokinet (1993) 1.04
Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis. Blood (1989) 1.03
Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function. J Lab Clin Med (1981) 1.03
Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor. Proc Natl Acad Sci U S A (1983) 1.02
Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia (1998) 1.01
Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther (1994) 1.01
Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. J Immunol (1981) 1.00
Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood (1997) 1.00
Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type I and type II. Br J Haematol (1981) 1.00
Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest (1987) 1.00
Bone marrow and lymph node cells in the rejection of skin allografts in mice. Immunology (1970) 0.99
Interaction between platelets and von Willebrand factor provides a new scheme for primary haemostasis. Nat New Biol (1973) 0.98
Peptides and histamine release from rat peritoneal mast cells. Eur J Pharmacol (1985) 0.97
Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. Biophys J (1996) 0.97
Effect of recombinant human interleukin-1 beta and tumor necrosis factor alpha on liver cytochrome P-450 and serum alpha-1-acid glycoprotein concentrations in the rat. Drug Metab Dispos (1990) 0.96
[Demonstration of the presence during acute inflammatory reactions of a serum factor mitogenic macrophages (author's transl)]. J Pharmacol (1981) 0.96
Endothelial binding sites for heparin. Specificity and role in heparin neutralization. Biochem J (1986) 0.95
High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J Autoimmun (1997) 0.95
Role of surface glycoproteins in human platelet function. Thromb Haemost (1976) 0.95
An appraisal of the interrelationships between prostaglandins and cyclic nucleotides in inflammation. Biomedicine (1976) 0.94
The value of multifactorial screening for anti-inflammatory activity as shown by coumarin. J Pathol (1977) 0.94
Comparative degradation of adenylnucleotides by cultured endothelial cells and fibroblasts. Biochem Biophys Res Commun (1978) 0.94
A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes (2001) 0.94
Substance-P-like levels in inflammatory exudates. Inflammation (1988) 0.93
C1 and human platelets. II. Detection by immunological methods and role. Immunology (1976) 0.93
Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem Pharmacol (1992) 0.93
Platelet aggregation in washed suspensions. Scand J Haematol (1971) 0.92
Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation. Thromb Haemost (1984) 0.92
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. J Lab Clin Med (1976) 0.92
Heterogeneity of fetal growth in type 1 diabetic pregnancy. Diabetes Metab (2001) 0.92
Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study. Diabetologia (2010) 0.92
Platelets from "giant platelet syndrome (BSS)" are discocytes and normal sized. J Lab Clin Med (1978) 0.91
Acute non-specific inflammatory reactions and protection against experimental Candida albicans infection. Agents Actions (1981) 0.91
Biological findings in Von Willebrand's pedigrees: implications for inheritance. J Clin Pathol (1967) 0.91
Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. I. Effect of neuraminidase. Pathol Biol (Paris) (1973) 0.91
Staurosporine, a protein kinase inhibitor, up-regulates the stimulation of human neutrophil respiratory burst by N-formyl peptides and platelet activating factor. Biochem Biophys Res Commun (1990) 0.91
Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients). Am J Med (1968) 0.91
New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides. Blood (1998) 0.91
The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab (2009) 0.91
Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat. Agents Actions (1984) 0.90
Induction of macrophage DNA synthesis in vitro, by non-immunological inflammatory sera: effect of irradiation and thymus or bone marrow cell reconstitution. J Pathol (1980) 0.90
Negative regulation of mitogen-activated protein kinase activation by integrin alphaIIbbeta3 in platelets. J Biol Chem (1997) 0.90
Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function. Eur J Biochem (1986) 0.90
Induction of macrophage DNA synthesis in vitro by non-immunological inflammatory exudates: effect of irradiation and thymus or bone marrow cell reconstitution. J Pathol (1978) 0.90
Heart failure responding to octreotide in patient with acromegaly. Lancet (1989) 0.90
C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG. Immunology (1976) 0.90
Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). Diabetes Metab (2004) 0.90
Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium. J Lab Clin Med (1983) 0.90
Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol). Thromb Haemost (1991) 0.89